Correlation between CT features and tumor angiogenesis in renal cell carcinoma and renal pelvic transitional cell carcinoma

Chinese Journal of Medical Imaging Technology

Volumn 22, Issue 6, 2006, Pages 933-937

  Wang, Jin Hong ^a   Min, Peng Qiu ^a   Zhang, Xiu Hui ^a   Liu, Rong Bo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Renal cell carcinoma; Tomography; Transitional cell carcinoma; Tumor angiogenesis; X ray computed

Indexed keywords

CD34 ANTIGEN; CONTRAST MEDIUM; VASCULOTROPIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PELVIS CARCINOMA; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TISSUE BLOOD FLOW; TRANSITIONAL CELL CARCINOMA; TUMOR VASCULARIZATION;

EID: 33746106426     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Passe TJ, Bluemke DA, Siegelman SS. Tumor angiogenesis: tutorial on implications for imaging [J]. Radiology, 1997, 203(2):593-600.
2. Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1):9-19.
3. Buadu LD, Murakami JJ, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis[J]. Radiology, 1996, 200(3):639-649.
4. Zagzag D, Goldenberg M, Brem S. Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model [J]. AJR, 1989, 153 (1):141-146.
5. Orel SG, Schnall MD, LiVolsi VA, et al. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation[J]. Radiology, 1994,190(2):485-493.
6. Hawighorst H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival [J]. Cancer Res, 1998, 58(1):3598-3602.
7. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitoger[J]. Science, 1989, 246 (4935):1306-1309.
8. Ma J, Zhou XJ, Zhang TH, et al. Clinicopathologic study of angiogenesis in human hepatocellular carcinoma[J]. Chin J Pathol, 2000, 29 (4): 248-251.
9. Zheng SX, Roan YB, Wu ZB, et al. The relationship between VEGF expression in hepatic carcinoma and metastasis of hepatic carcinoma[J]. Chin J Pathol, 1998, 27(6): 456-457.
10. Lu M, Jiang YQ, Wang RN. The relationship of vascular endothelial growth factor and angiogenesis to the progression of gastric carcinoma[J]. Chin J Pathol, 1998, 27(4): 278-281.
11. EI-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J]. Hepatology, 1998, 27 (6):1554-1562.
12. Wang JH, Min PQ, Liu RB, et al. Correlation study of CT features with time window in renal cell carcinoma[J]. Chin J Med Imaging Technol, 2004, 20(11):1721-1724.
13. Geng JM, Yan MM, Chen H, et al. Shape and measurement of intratumor vascularity in renal cell carcinoma [J]. Pract Oncol, 1996, 10(4):59-62.
14. Yuan M. Angiogenesis and tumor treatment [J]. Chin J Cancer Biother, 1997, 4 (1):1-4.
15. Folkman J, Shing Y. Angiogenesis [J]. J Biol Chem, 1992, 267 (16):10931-10934.